Condition

Pulmonary; Hypertension

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common interventions6

Lead sponsors shown4

Clinical trials

4 shown

Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic HerniaNCT02986087 · 2016-11-01

RECRUITING

A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection FractionNCT02980068 · 2017-08-28

COMPLETED

Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial HypertensionNCT02981082 · 2016-12-01

TERMINATED

Reversal of Right Ventricular Steatosis in Pulmonary HypertensionNCT02966899 · 2016-11-01

WITHDRAWN

Common interventions

14N NitrateDRUG1 15N NitrateDRUG1 Dimethyl Fumarate (DMF)DRUG1 Fetal Tracheal OcclusionDEVICE1 Omega-3 fatty acidsDIETARY_SUPPLEMENT1 Placebo Oral TabletDRUG1

Leading sponsors

Children's Hospital Medical Center, Cincinnati 1 Gladwin, Mark, MD 1 Robert Lafyatis 1 Wen-Chih Wu 1

Trial status mix

COMPLETED1

RECRUITING1

TERMINATED1

WITHDRAWN1

Phase mix

NA2

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.